These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 9638166)
1. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity]. Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions. Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464 [TBL] [Abstract][Full Text] [Related]
3. [Usefulness of the modified Dixon technique associated with gadolinium administration in the characterization of adrenal masses]. Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Vito AD; Perri G Radiol Med; 1997 Mar; 93(3):218-24. PubMed ID: 9221413 [TBL] [Abstract][Full Text] [Related]
4. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques. Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481 [TBL] [Abstract][Full Text] [Related]
6. [Adrenal myelolipomas: their magnetic resonance assessment]. Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Di Vito A; Perri G Clin Ter; 1996 Nov; 147(11):549-57. PubMed ID: 9264908 [TBL] [Abstract][Full Text] [Related]
7. [Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal]. Maurea S; Cuocolo A; Reynolds JC; Choyke PL; Keiser HR; Neumann RD; Salvatore M Radiol Med; 1993 Jun; 85(6):803-8. PubMed ID: 8337438 [TBL] [Abstract][Full Text] [Related]
8. [Role of MR in characterizing expansive lesions of the adrenal gland]. Squillaci E; Vidiri A; Crecco M; Lo Presti G; Simonetti G Radiol Med; 1992 Jun; 83(6):770-6. PubMed ID: 1502357 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of thymic epithelial tumors. Kushihashi T; Fujisawa H; Munechika H Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410 [TBL] [Abstract][Full Text] [Related]
10. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885 [TBL] [Abstract][Full Text] [Related]
11. Markedly high signal intensity lesions in the uterine cervix on T2-weighted imaging: differentiation between mucin-producing carcinomas and nabothian cysts. Li H; Sugimura K; Okizuka H; Yoshida M; Maruyama R; Takahashi K; Miyazaki K Radiat Med; 1999; 17(2):137-43. PubMed ID: 10399782 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of the adrenal gland. Boland GW; Lee MJ Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177 [TBL] [Abstract][Full Text] [Related]
13. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image]. Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696 [TBL] [Abstract][Full Text] [Related]
14. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642 [TBL] [Abstract][Full Text] [Related]
15. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance]. Torricelli P; Montanari N; De Santis M; Pollastri C Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898 [TBL] [Abstract][Full Text] [Related]
16. Characterization of adrenal masses using MR imaging with histopathologic correlation. Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092 [TBL] [Abstract][Full Text] [Related]
17. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors. Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343 [TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis]. Golfieri R; Cherryman GR; Olliff JF; Husband JE Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578 [TBL] [Abstract][Full Text] [Related]
19. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951 [TBL] [Abstract][Full Text] [Related]
20. Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI. Nakamura S; Namimoto T; Morita K; Utsunomiya D; Oda S; Nakaura T; Hirai T; Yamashita Y J Magn Reson Imaging; 2012 Jan; 35(1):95-102. PubMed ID: 22002867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]